HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

N-[(2S,3R,4E)-1-{[4-O-(alpha-L-glycero-Hexopyranosyl)-beta-D-glycero-hexopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]dodecanamide

HCID 46891736
New reaction
Print
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
474943-80-1
Standard SMILES
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O)C(O)C2O)C(O)C1O)NC(=O)CCCCCCCCCCC
InChIKey
KNWHKVBHCLQVFX-NKNVVQMUSA-N
Molecular formula
C42H79NO13
Average molar mass
806.1 g/mol
Monoisotopic mass
805.55514157

Names & identifiers

Preferred name
N-[(2S,3R,4E)-1-{[4-O-(alpha-L-glycero-Hexopyranosyl)-beta-D-glycero-hexopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]dodecanamide
IUPAC
N-[(E,2S,3R)-1-[(2R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]dodecanamide
English name
D-lactosyl--1,1' N-lauroyl-D-erythro-sphingosine
Molecular formula
C42H79NO13
Molecular weight
806.08

Names & synonyms

DTXSID60677050N-[(2S,3R,4E)-1-{[4-O-(alpha-L-glycero-Hexopyranosyl)-beta-D-glycero-hexopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]dodecanamideC12 Lactosyl(ss) Ceramide(d18:1/12:0)C12 Lactosyl(β) Ceramide (d18:1/12:0)LacCer d18:1/12:0 (Galb1,4GlcbCeramide)D-lactosyl--1,1' N-lauroyl-D-erythro-sphingosineD-lactosyl-β-1,1' N-lauroyl-D-erythro-sphingosineDodecanamide, N-[(1S,2R,3E)-1-[[(4-O-β-D-galactopyranosyl-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-

Database identifiers

CAS
474943-80-1
PubChem CID
46891736
DTXSID
DTXSID60677050

Properties

Computed structural properties

XLogP
7
Topological polar surface area
228 Ų
Hydrogen bond donors
9
Hydrogen bond acceptors
13
Rotatable bonds
32
Heavy atoms
56
Formal charge
0
Complexity
1,010

Physicochemical properties

Boiling point
966 · 966.0±65.0 °C(Predicted)
Density
1.18 · 1.18±0.1 g/cm3(Predicted)
pka
12.79 · 12.79±0.70(Predicted)
form
Solid
color
White to off-white
InChIKey
KNWHKVBHCLQVFX-NKNVVQMUSA-N
SMILES
[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O[C@H](O2)[C@H](O)[C@@H](O)[C@H]([C@H]2CO)O
FDA UNII
7 YDL92Q · MEC7YDL92Q
UNSPSC Code
12352211 · 12352211
NACRES
25 · NA.25
Symbol(GHS)
2 · GHS02,GHS07
Signal word
Danger
Hazard statements
225 · H225-H319
Precautionary statements
210 · P210-P305+P351+P338
WGK Germany
3 · WGK 3
Storage Class
11 · 11 - Combustible Solids

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
Signal word
Danger
Symbol(GHS)
GHS02,GHS07
Storage Class
11 - Combustible Solids
Hazard statements
H225-H319
Precautionary statements
P210-P305+P351+P338

Chemistry & industry

Applications · 1 item

UsesTrihexosylceramide (d18:1/12:0) is a type of Trihexosylceramide. In the renal tissue of heterozygous Fabry's disease, the cytoplasm of glomerular epithelial cells appears foamy. Trihexosylceramide accumulated in glomerular epithelial cells as identified by immunostaining[1][2].

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes